• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • Samples
    • MRI Images
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

Spotlight on the University Of Oxford

2018-10-29News

On World Alzheimer’s Day, the members of the EPAD initiative have reached a new milestone where the EPAD Longitudinal Cohort Study (LCS) has screened more than 1,000 research participants. Within EPAD, the team at University Of Oxford (UOF) has been recruiting successfully and recruited the 1,000th participant.

Dr Vanessa Raymont, principal investigator of the EPAD project in Oxford was delighted by the success of her team: “’The Oxford site staff are exceptionally proud to have recruited the 1,000th participant – it’s all about the team work!”.

In this newsflash, we get to know the UOF team behind EPAD including their activities already done to recruit, engage and retain research participants. Check out their best practices below:

Do you have any top tips to share for running the LCS efficiently at your site? UOF: Organisation is key! We make sure that the all parts of the visits are booked in as early as possible (sometimes up to 2 months before!) to avoid any issues down the line with the visit windows and limited resource availability. Also, as we work across multiple NHS and University teams, clear communication pathways and processes are vital. With regards to efficient communication with potential participants’, we would highly recommend using the informational videos created by the Alzheimer’s Society (available on YouTube). These videos demonstrate many of the procedures involved in EPAD visits from a participant’s perspective, and lots of our participants have fed back that they found them very useful in helping them make a decision about participation.

How are you able to find suitable subjects for the cohort? UOF: We aim to tap into as many wide-ranging recruitment sources as possible so that we can offer this great opportunity to all those who are interested. By working closely with local memory clinics we ensure that people experiencing mild cognitive impairment are given the chance to get involved, as well as their interested family members, friends and carers. We also use registers such as the national ‘Join Dementia Research’ platform and our own healthy volunteer register ‘OxDARE’, to find suitable participants across Oxfordshire and Buckinghamshire.

Are you organising teleconferences (TC) with other EPAD sites in England? UOF: We have monthly TC’s with the TDC coordinators, where we discuss our progress, successes and struggles. In England, there is quite a lot of overlap in terms of recruitment sources and strategies, as well as contractual arrangements, so it is key to keep in touch, share our experiences and help support each other. As the lead site for the region, Oxford aims to support the CRO and the TDC’s in its region in the setup process, day to day management, as well as in the long term.

Have you organised or attended any events/conferences which have been beneficial for recruitment into EPAD? UOF: Over the summer we have attended multiple different events in and around Oxford to boost recruitment into EPAD and promote dementia research more generally. From providing an informational stall at our hospital’s open day as part of Oxford Open Doors, to giving a talk on current themes in dementia research at a local “Matters of Memory” event, we find that engaging with the public and clinical colleagues about the science of dementia prevention is beneficial for recruitment into EPAD. We are aiming to continue and actually increase these local events in the future. We are currently planning an informational event for carers in partnership with a local care home later in October, as well as an Oxford educational event around dementia prevention.

Pictured: from left to right: Amy Chinner (Research Assistant), Sophie Walker (back, Research Assistant), Jasmine Blane (front, Research Assistant), Laura Eshmene (Research Facilitator, back), Leona Wolters (Research Assistant, front), Sarah Mather (back, Clinical Research Assistant), Jen Lawson (Senior Trials Manager), Emily Broadhurst (Clinical Research Assistant), Dr Vanessa Raymont (Principal Investigator), Prof John Gallacher (National Lead for England and Wales), Juliana Ballaminut (Clinical Research Nurse), Delia Gheorghe (National Lead Coordinator for England and Wales), Dr Sarah Bauermeister (Psychometric Analyst).

EPAD Update:

September was the best month so far in the EPAD LCS for number of participants screened, there was a total of 105 screened across 20 European centres. Special mentions this month go to VUmc (Amsterdam, Netherlands) as the team screened 13 research participants in September for their inclusion in the EPAD study. We are pleased that Bruno Dubois’s team in Paris La Salpetriere (France) and Pablo Martinez-Lage’s team in San Sebastian (Spain) screened both 12 new participants in September.

 

Share this post
FacebookTwitterLinkedInGoogle+
Related posts
Closing EPAD article published in the Alzheimer Europe magazine
2021-02-24
Alzheimer Europe launches a report on data sharing in dementia research
2021-02-23
Local actions to keep the EPAD Longitudinal Cohort data collection going
2021-02-17
Neuronet releases its Knowledge Base dashboard
2021-02-01
The final EPAD dataset is now available to the entire research community
2020-11-30
ALZFORUM
Alzforum conference blog mentions EPAD
2020-11-30
Latest News
  • Closing EPAD article published in the Alzheimer Europe magazine
    2021-02-24
  • Alzheimer Europe launches a report on data sharing in dementia research
    2021-02-23
  • Local actions to keep the EPAD Longitudinal Cohort data collection going
    2021-02-17
  • Neuronet releases its Knowledge Base dashboard
    2021-02-01
  • The final EPAD dataset is now available to the entire research community
    2020-11-30
View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

.@AlzheimerEurope has published a new edition of its “Dementia in Europe” magazine. It includes a closing article on @IMI_EPAD. Our co-leads @craig_ritchie68 and Serge Van der Geyten, reflect on the achievements of the project. Download the PDF here: bit.ly/DementiaInEuro… twitter.com/AlzheimerEurop…

reply retweet favorite
12:40 pm · 2021-02-24
Twitter
EPAD
EPAD
@IMI_EPAD

Last week, we held the first local @IMI_EPAD community meeting among the Scottish research sites, collaborators, academics & scientists who have been involved in our Longitudinal Cohort Study and now continue to contribute to the study locally More info⤵️ ep-ad.org/2021/02/17/loc… pic.twitter.com/MTKmanCURk

reply retweet favorite
6:51 am · 2021-02-24
Twitter
EPAD
EPAD
@IMI_EPAD

Check out the new @AlzheimerEurope report on #DataSharing in #dementia #research, which reviews recent changes in EU research policy and sets out recommendations to improve data sharing. It includes case studies from ADNI, @IMI_EPAD and @IMI_EMIF. ⬇️ Bit.ly/DataSharing_AE twitter.com/AlzheimerEurop…

reply retweet favorite
2:39 pm · 2021-02-23
Twitter
EPAD
EPAD
@IMI_EPAD

Scottish @IMI_EPAD members have been invited to join the first #EPADcommunity meeting. Today, we're discussing about publications, #data access, communications, participant panel, #network & #collaborations. Nice to see some #epadistas sharing their insights 👨‍⚕️👩‍🔬👩‍💻 pic.twitter.com/O1hLAVxk0Q

reply retweet favorite
2:23 pm · 2021-02-17
Twitter
EPAD
EPAD
@IMI_EPAD

The new issue of the @IMI2_NEURONET #newsletter is out with latest news on @IMI_EPAD, @IMI_AMYPAD, @RADARCNS among others. Find out more here: bit.ly/Neuronet-Newsl… twitter.com/IMI2_NEURONET/…

reply retweet favorite
2:12 pm · 2021-02-15
Copyright © 2015-19 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.